pBR322 vectors having tetracycline-dependent replication
Related Experiment Video
Updated: Mar 25, 2026

High-Resolution Comparison of Bacterial Conjugation Frequencies
Published on: January 10, 2019
1Department of Microbiology, University of Illinois, B103 Chemical and Life Sciences Laboratory, 601 S. Goodwin Ave., Urbana, IL 61801, USA; Department of Biochemistry, University of Illinois, 419 Roger Adams Laboratory, 600 South Mathews Ave., Urbana, IL 61801, USA.
Abstract:
Few Escherichia coli cloning vectors are available that can both be stably maintained and efficiently cured. One such vector is pAM34, a pBR332 derivative constructed by Gil and Bouché (1991). Replication of this plasmid is driven by the lacZYA promoter under control of a gratuitous inducer. However, lac operator-repressor interactions are also used to regulate many expression systems which limit the utility of pAM34. In this report pAM34 has been modified by replacement of the lac regulatory elements with those of the transposon Tn10 tetracycline resistance module. This resulted in medium copy number plasmids that are dependent on the presence of tetracycline (or less satisfactorily, anhydrotetracycline) for replication. The tetracycline-dependent plasmids are rapidly lost in the absence of tetracycline and plasmid loss is markedly accelerated when the host strain expresses a tetracycline efflux pump.
Related Concept Videos
Prokaryotic DNA Replication
DNA Bacteriophages
Viral Replication: Lytic Cycle

